Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Colorcon
McKesson
Argus Health
Cantor Fitzgerald
Boehringer Ingelheim
Julphar
QuintilesIMS

Generated: May 25, 2018

DrugPatentWatch Database Preview

CEFTAZIDIME Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for CEFTAZIDIME
Pharmacology for CEFTAZIDIME
Synonyms for CEFTAZIDIME
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl}amino)-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(1-hydroxy-2-methyl-1-oxopropan-2-yl)oxyiminoacetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(1-carboxy-1-methyl-ethoxy)imino-acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-[[(6R,7R)-7-[[(2Z)-(2-AMINO-4-THIAZOLYL)[(1-CARBOXY-1-METHYLETHOXY)IMINO] ACETYL] AMINO]-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO[4.2.0] OCT-2-EN-3-YL]METHYL]PYRIDINUM HYDROXIDE INNER SALT
1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridin-1-ium
72558-82-8
78439-06-2
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-(pyridinium-1-ylmethyl)-3,4-didehydrocepham-4-carboxylate
AB00513848
AB00513848-02
AB02837
AB1009357
AC1NUK7U
AK163513
AKOS015951273
AN-37419
BDBM50420259
BIDD:GT0734
C06889
C22H22N6O7S2
CAZ
Cefprozil, Antibiotic for Culture Media Use Only
Ceftazidim
ceftazidima
Ceftazidima [INN-Spanish]
CEFTAZIDIME (ARGININE FORMULATION)
Ceftazidime (INN)
Ceftazidime (TN)
CEFTAZIDIME ACID
Ceftazidime anhydrous
Ceftazidime Sodium In Plastic Container
ceftazidimum
Ceftazidimum [INN-Latin]
Ceftazidine
Ceptaz
Ceptaz (TN)
CHEBI:3508
CHEMBL44354
CS-2810
D07654
DB00438
DTXSID5022770
Fortaz
Fortaz In Plastic Container
Fortum
GR 20263
HMS2090M13
HY-B0593
MolPort-006-137-763
Pentacef
Q-200811
SCHEMBL36849
SN 401
Tazicef
Tazidime
Tazidime In Plastic Container

US Patents and Regulatory Information for CEFTAZIDIME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-002 Nov 20, 1985 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma Ltd CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 065482-001 May 28, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Acs Dobfar CEFTAZIDIME ceftazidime INJECTABLE;INJECTION 062640-001 Nov 20, 1985 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-001 Apr 29, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cipla
Federal Trade Commission
QuintilesIMS
Baxter
Argus Health
Medtronic
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.